Multi-analyte monitoring sensor

By designing a multi-analyte monitoring sensor in a biosensor, using the working electrode and polymer film layer structure, the problem of difficulty in monitoring multiple analytes at the same time in the prior art is solved, and the monitoring effect of high sensitivity and accuracy is achieved.

WO2024240266A1PCT designated stage expired Publication Date: 2024-11-28SHENZHEN SISENSING TECH CO LTD
View PDF 6 Cites 0 Cited by

Patent Information

Application Number
PCT/CN2024/095376
Authority / Receiving Office
WO · WO
Patent Type
Applications
Current Assignee / Owner
Priority Date
2023-05-25
Filing Date
2024-05-25
Publication Date
2024-11-28

AI Technical Summary

Technical Problem

Existing biosensors are difficult to monitor multiple analytes efficiently at the same time, and the production process is complex and the sensitivity and accuracy are insufficient.

Method used

Design a multi-analyte monitoring sensor, adopting a structure including a working electrode, an enzyme sensing layer and a polymer film layer, by setting enzyme layers of different analytes on the two working electrodes, and covering the enzyme layer with a polymer film layer , simplify the production process and improve the stability and sensitivity of the sensor.

Benefits of technology

Simultaneous monitoring of multiple analytes is achieved, the production process is simplified, the sensitivity and accuracy of the sensor is improved, and the biocompatibility and safety performance are enhanced.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN2024095376_28112024_PF_FP_ABST
    Figure CN2024095376_28112024_PF_FP_ABST
Patent Text Reader

Abstract

The present disclosure describes a multi-analyte monitoring sensor, comprising: working electrodes, an enzyme sensing layer disposed on the working electrodes, and a polymer film layer, wherein the working electrodes comprise a first working electrode and a second working electrode; the enzyme sensing layer comprises a first analyte enzyme layer and a second analyte enzyme layer, the first analyte enzyme layer being arranged on the first working electrode, the second analyte enzyme layer being arranged on the second working electrode, and the second analyte being different from the first analyte; and the polymer film layer is permeable to the first analyte and the second analyte and covers the first analyte enzyme layer and the second analyte enzyme layer. By means of the present disclosure, a multi-analyte monitoring sensor capable of monitoring various analytes at the same time can be provided.
Need to check novelty before this filing date? Find Prior Art

Description

Multi-analyte monitoring sensors Technical Field

[0001] The present disclosure relates generally to the field of biosensors, and more particularly to a multi-analyte monitoring sensor. Background Art

[0002] Biosensors are analytical devices that tightly combine biological materials, bio-derived materials, or biomimetic materials with optical, electrochemical, temperature, piezoelectric, magnetic, or micromechanical physical and chemical sensors or sensing microsystems. They can usually be used to quickly detect certain specific chemicals in the human body, such as glucose, ketone bodies, uric acid, and a series of amino acid compounds.

[0003] Some substances in the human body may be related to each other. For example, there is a certain correlation between the blood ketone level and the blood sugar level in the human body. When the blood sugar is too high, the body lacks insulin, or a ketogenic diet is taken, the body will metabolize fat to produce ketone bodies. When the amount of ketone bodies exceeds the metabolic capacity of the liver, complications of diabetes are likely to occur.

[0004] Therefore, monitoring different substances in the human body at the same time can help the host understand the physical condition more conveniently and comprehensively.

[0005] Summary of the Invention

[0006] The present disclosure is proposed in view of the above-mentioned situation, and its object is to provide a multi-analyte monitoring sensor capable of monitoring multiple analytes simultaneously.

[0007] To this end, the first aspect of the present disclosure provides a multi-analyte monitoring sensor, which includes a working electrode, an enzyme sensing layer arranged on the working electrode, and a polymer film layer, wherein the working electrode includes a first working electrode and a second working electrode; the enzyme sensing layer includes a first analyte enzyme layer and a second analyte enzyme layer, the first analyte enzyme layer is arranged on the first working electrode, the second analyte enzyme layer is arranged on the second working electrode, and the second analyte is different from the first analyte; the polymer film layer is permeable to the first analyte and the second analyte and covers the first analyte enzyme layer and the second analyte enzyme layer.

[0008] In the multi-analyte monitoring sensor involved in the present disclosure, by setting two analyte enzyme layers on the two working electrodes of the sensor, the concentration levels of two different analytes in the tissue fluid can be detected separately; the polymer film layer can simultaneously pass through the two analytes, and by covering the first analyte enzyme layer and the second analyte enzyme layer with the polymer film layer, the permeation of the two analytes can be restricted, which is also conducive to improving the stability of the sensor; in addition, due to the small size of the biosensor, when processing the sensor, if different semipermeable membranes need to be coated on different analyte electrodes respectively, the precision requirements of the coating process will be very high. Compared with the solution of setting different semipermeable membranes on the first analyte enzyme layer and the second analyte enzyme layer respectively, the polymer film layer in the present invention can simultaneously pass through the two analytes, thereby simplifying the manufacturing process of the sensor while maintaining the high sensitivity and accuracy of the sensor. Thus, a sensor with a simple manufacturing process and capable of monitoring multiple analytes simultaneously can be provided.

[0009] In addition, in the multi-analyte monitoring sensor according to the first aspect of the present disclosure, optionally, the first analyte is glucose, thereby enabling glucose monitoring.

[0010] In addition, in the multi-analyte monitoring sensor of the first aspect of the present disclosure, optionally, the second analyte is any one of β-hydroxybutyrate, lactate, ethanol, uric acid, urea, acetylcholine, amylase, bilirubin, cholesterol, chorionic gonadotropin, creatine kinase, creatine, creatinine, DNA, fructosamine, glutamine, hormones, ketone bodies, lactate, oxygen, peroxide, prostate-specific antigen, prothrombin, RNA, troponin, digitoxin, digoxin, theophylline, warfarin, or antibiotics. Thus, different analytes can be selected for monitoring based on different needs.

[0011] In addition, in the multi-analyte monitoring sensor involved in the first aspect of the present disclosure, optionally, the polymer membrane layer includes a membrane polymer, and the membrane polymer is a vinyl pyridine polymer, polyurethane, sodium polystyrene sulfonate, poly(N-isopropylacrylamide), polyacrylic acid, polyvinyl alcohol, polyvinyl pyrrolidone, poly(oligo(ethylene glycol) methyl ether methyl methacrylate), or a block copolymer or blend of the above polymers. This can facilitate the formation of a polymer membrane layer that has a restrictive permeation effect on two analytes and is biocompatible. The polymer membrane layer can help control the amount of the analyte within the linear range of the sensor, thereby improving the sensitivity and accuracy of the sensor.

[0012] In addition, in the multi-analyte monitoring sensor according to the first aspect of the present disclosure, the polymer membrane layer optionally further comprises a cross-linking agent and a modifier, and the mass fraction of the membrane polymer in the polymer membrane layer is 80% to 100%. This facilitates the formation of a biocompatible polymer membrane layer that restricts the permeation of two analytes. The polymer membrane layer helps control the amount of the analytes within the linear range of the sensor, thereby improving the sensitivity and accuracy of the sensor.

[0013] In addition, in the multi-analyte monitoring sensor according to the first aspect of the present disclosure, optionally, the polymer film layer is biocompatible, thereby helping to improve the safety performance of the sensor.

[0014] In addition, in the multi-analyte monitoring sensor according to the first aspect of the present disclosure, optionally, the polymer membrane layer includes a first membrane layer that is biocompatible and has a diffusion-limiting effect on the first analyte and the second analyte.

[0015] In addition, in the multi-analyte monitoring sensor involved in the first aspect of the present disclosure, optionally, the polymer membrane layer includes a first membrane layer having a diffusion-limiting effect on the first analyte and the second analyte, and a second membrane layer having biocompatibility, and the second membrane layer is farther away from the enzyme sensing layer than the first membrane layer.

[0016] In addition, in the multi-analyte monitoring sensor according to the first aspect of the present disclosure, optionally, the sensitivity of the first working electrode differs from the sensitivity of the second working electrode by no more than 6 times. In this case, on the one hand, this can help reduce the current difference between the two working electrodes and reduce electric field interference with the sensor system; on the other hand, if the sensitivity difference between the two analyte electrodes is too large, the analyte reaction at the high-sensitivity electrode may be greater, thereby affecting the reaction between the low-sensitivity electrode and the analyte. Setting the sensitivity difference between the two electrodes to no more than 6 times can also prevent this from occurring, thereby helping to improve the measurement accuracy of the sensor.

[0017] In addition, in the multi-analyte monitoring sensor involved in the first aspect of the present disclosure, optionally, the area of ​​the first analyte enzyme layer is greater than or smaller than the area of ​​the second analyte enzyme layer. Since the amount of the two analytes that can pass through the polymer film layer is different, the area of ​​the first analyte enzyme layer is set to be greater than or smaller than the area of ​​the second analyte enzyme layer, and a suitable scheme can be selected according to the amount of the two analytes that can pass through the polymer film layer. For example, when the amount of the first analyte that can pass through the polymer film layer is less than the amount of the second analyte, by configuring the area of ​​the first analyte enzyme layer to be greater than the area of ​​the second analyte enzyme layer, the contact area between the first analyte enzyme layer and the first analyte can be increased, thereby minimizing the current difference between the two working electrodes as much as possible, helping to make the current on the two working electrodes at the same level, reducing the interference of the electric field on the sensor system, and further improving the measurement accuracy of the sensor.

[0018] In addition, in the multi-analyte monitoring sensor involved in the first aspect of the present disclosure, optionally, the polymer film layer includes a negatively charged film layer that has a diffusion-limiting effect on the first analyte and the second analyte. In this case, the negatively charged film layer has a certain repulsive effect on negatively charged substances, and therefore can have a stronger diffusion-limiting effect on negatively charged analytes. When the first analyte and the second analyte are neutral molecules and negatively charged molecules, respectively (for example, the first analyte is glucose and the second analyte is β-hydroxybutyrate), and the permeable amount of the negatively charged molecule is larger, providing a negatively charged film layer can help reduce the difference in permeable amount between the two analytes, thereby minimizing the current difference between the two working electrodes and improving the measurement accuracy of the sensor.

[0019] In addition, in the multi-analyte monitoring sensor involved in the first aspect of the present disclosure, optionally, the second analyte is β-hydroxybutyrate, and the second analyte enzyme layer includes hydroxybutyrate dehydrogenase, diaphorase, a coenzyme, and an electron mediator. In the second analyte enzyme layer, the mass fraction of hydroxybutyrate dehydrogenase is 10% to 35%, the mass fraction of diaphorase is 5% to 40%, the mass fraction of the coenzyme is 10% to 45%, and the mass fraction of the electron mediator is 10% to 50%. In this case, the reaction sensitivity of the second analyte enzyme layer to β-hydroxybutyrate can be improved, and by providing a macromolecular electron mediator in the enzyme layer, the hydroxybutyrate dehydrogenase can be covalently bound to the electron mediator, thereby further improving stability.

[0020] In addition, in the multi-analyte monitoring sensor involved in the first aspect of the present disclosure, optionally, the sensor further includes a substrate, and the working electrode is disposed on the substrate.

[0021] In addition, in the multi-analyte monitoring sensor of the first aspect of the present disclosure, the sensor optionally further includes a reference electrode and a counter electrode, wherein the first working electrode and the second working electrode are respectively located on opposite sides of the substrate, and the reference electrode and the counter electrode are respectively located on opposite sides of the substrate. In this case, a four-electrode dual-path detection sensor can be formed, and placing the four electrodes, two by two, on opposite sides of the substrate can improve substrate utilization while further reducing electric field interference with the sensor system.

[0022] According to the present disclosure, a multi-analyte monitoring sensor can be provided, which can monitor multiple analytes simultaneously, has a simple manufacturing process, and has high sensitivity and stability. BRIEF DESCRIPTION OF THE DRAWINGS

[0023] The present disclosure will now be explained in further detail, by way of example only, with reference to the accompanying drawings, in which:

[0024] FIG. 1 is a schematic diagram illustrating a multi-analyte monitoring sensor according to an example of the present disclosure.

[0025] FIG. 2A is a schematic front view illustrating a multi-analyte monitoring sensor according to an example of the present disclosure.

[0026] FIG. 2B is a schematic diagram showing the reverse side of a multi-analyte monitoring sensor according to an example of the present disclosure.

[0027] FIG. 3 is a schematic diagram illustrating a polymer film layer according to an example of the present disclosure.

[0028] FIG. 4 is a graph showing a response current-test concentration curve of Example 1 of the blood glucose+blood ketone sensor according to the present disclosure.

[0029] FIG5 is a picture showing a monitoring probe of Example 2 of the blood glucose + blood ketone sensor according to the present disclosure.

[0030] FIG6 is a graph showing a response current-test time curve of Example 2 of the blood glucose+blood ketone sensor according to the present disclosure.

[0031] FIG. 7 is a graph showing a response current-test concentration curve of Example 2 of the blood glucose+blood ketone sensor according to the present disclosure.

[0032] FIG8 is a graph showing a glucose / sodium β-hydroxybutyrate response current-time curve of Example 2 of the blood glucose+blood ketone sensor according to the present disclosure.

[0033] FIG. 9 is a graph showing a response current-test concentration curve of Example 3 of the blood glucose+blood ketone sensor according to the present disclosure.

[0034] FIG. 10 is a picture showing a monitoring probe of Example 4 of the blood glucose + blood ketone sensor according to the present disclosure.

[0035] FIG. 11 is a photograph showing a monitoring probe of Example 5 of the blood glucose + blood ketone sensor according to the present disclosure.

[0036] FIG. 12 is a photograph showing a monitoring probe of Example 6 of the blood glucose + blood ketone sensor according to the present disclosure.

[0037] FIG. 13 is a photograph showing a monitoring probe of Example 7 of the blood glucose + blood ketone sensor according to the present disclosure.

[0038] FIG. 14 is a picture showing a monitoring probe of Comparative Example 1 of the blood glucose + blood ketone sensor according to the present disclosure.

[0039] FIG. 15 is a graph showing a response current-test concentration curve of Comparative Example 1 of the blood glucose+blood ketone sensor according to the present disclosure.

[0040] FIG. 16 is a photograph showing a monitoring probe of Comparative Example 2 of the blood glucose + blood ketone sensor according to the present disclosure.

[0041] FIG. 17 is a graph showing a response current-test time curve of Comparative Example 2 of the blood glucose+blood ketone sensor according to the present disclosure.

[0042] FIG. 18 is a photograph showing a monitoring probe of Comparative Example 3 of the blood glucose + blood ketone sensor according to the present disclosure.

[0043] FIG. 19 is a picture showing the monitoring probe of Comparative Example 3 of the blood glucose + blood ketone sensor according to the present disclosure from another perspective.

[0044] FIG. 20 is a photograph showing a monitoring probe of Example 1 of the blood glucose + lactate sensor according to the present disclosure.

[0045] FIG. 21 is a graph showing a response current-test time curve of Example 1 of the blood glucose+lactic acid sensor according to the present disclosure.

[0046] FIG. 22 is a picture showing the monitoring probes of the blood ketone sensor of Example 1 and Comparative Examples 1-2 according to the present disclosure.

[0047] FIG. 23 is a picture showing monitoring probes coated with a polymer film layer according to Example 1 and Comparative Examples 1-2 of the blood ketone sensor of the present disclosure.

[0048] FIG. 24 is a graph showing response current versus test concentration in a linearity test of Example 1 of the blood ketone sensor according to the present disclosure.

[0049] FIG. 25 is a graph showing a response current-test concentration curve of a linearity test of Example 1 of the blood ketone sensor according to the present disclosure.

[0050] FIG. 26 is a graph showing a response current-test concentration curve of a stability test of Example 1 of the blood ketone sensor according to the present disclosure.

[0051] FIG. 27 is a graph showing a response current-test concentration curve of a stability test of Comparative Example 1 of the blood ketone sensor according to the present disclosure.

[0052] FIG. 28 is a graph showing a response current-test concentration curve of Comparative Example 2 of a stability test of the blood ketone sensor according to the present disclosure.

[0053] FIG. 29 is a graph showing response current versus test concentration in a linearity test of Comparative Example 3 of the blood ketone sensor according to the present disclosure.

[0054] FIG30 is a photograph showing a working electrode of Comparative Example 4 of the blood ketone sensor according to the present disclosure.

[0055] FIG31 is a photograph showing a monitoring probe of a sensor of Comparative Example 4 of the blood ketone sensor according to the present disclosure.

[0056] FIG. 32 is a graph showing a response current-test time curve of the sensor of Comparative Example 4 of the blood ketone sensor according to the present disclosure.

[0057] FIG33 is a photograph showing a working electrode of a blood ketone sensor according to Comparative Example 5 of the present disclosure.

[0058] FIG. 34 is a graph showing response current versus test concentration in a linearity test of Comparative Example 5 of the blood ketone sensor according to the present disclosure.

[0059] Explanation of the reference numerals: 10 ...monitoring probe, 11 ...substrate, 12 ...first working electrode, 121 ...first analyte enzyme layer, 13 ...second working electrode, 131 ...second analyte enzyme layer, 14 ...polymer membrane layer, 141 ...first membrane layer, 143 ...second membrane layer, 15 ...reference electrode, 16 ...counter electrode. DETAILED DESCRIPTION

[0060] The preferred embodiments of the present disclosure are described in detail below with reference to the accompanying drawings. In the following description, identical components are assigned identical reference numerals, and duplicate descriptions are omitted. In addition, the accompanying drawings are merely schematic, and the proportions of the dimensions of the components and the shapes of the components may differ from the actual ones.

[0061] It should be noted that the terms "including" and "having" and any variations thereof in this disclosure, such as a process, method, system, product or device that includes or has a series of steps or units, are not necessarily limited to those steps or units clearly listed, but may include or have other steps or units that are not clearly listed or are inherent to these processes, methods, products or devices.

[0062] In addition, the subheadings and the like in the following description of this disclosure are not intended to limit the content or scope of this disclosure, but are merely provided as a guide for reading. Such subheadings should not be understood as dividing the content of the article, nor should the content under the subheading be limited to the scope of the subheading.

[0063] A first aspect of the present disclosure relates to a multi-analyte monitoring sensor that can monitor multiple analytes. In the present disclosure, a multi-analyte monitoring sensor may also be referred to as a "multi-analyte sensor," a "dual-analyte sensor," a "physiological parameter sensor," or a "sensor," a "sensing probe," a "sensing probe," or an "implantable probe." Specifically, a sensor for two analytes may also be named after the analytes. For example, when the analytes monitored by the sensor are glucose and ketone bodies, the sensor may be referred to as a "glucose and ketone body sensor" or a "blood glucose and ketone sensor."

[0064] The sensor involved in the present disclosure can be used to monitor the physiological parameters of the host. The physiological parameters can be parameters such as glucose, urea, uric acid, ketone bodies and a series of amino acid compounds in the host. In the present disclosure, the sensor can also be used to detect the object to be detected in the host. The object to be detected can be a chemical substance in body fluids. For example, the object to be detected can be one or more of glucose, acetylcholine, amylase, bilirubin, cholesterol, chorionic gonadotropin, creatine kinase, creatine, creatinine, DNA, fructosamine, glutamine, hormones, ketone bodies, lactate, oxygen, peroxide, prostate-specific antigen, prothrombin, RNA, thyroid-stimulating hormone or troponin. In addition, the object to be detected can also be a drug in body fluids. For example, the object to be detected can be digitoxin, digoxin, theophylline, warfarin or an antibiotic (such as gentamicin, vancomycin, etc.).

[0065] A second aspect of the present disclosure relates to a semipermeable membrane of a multi-analyte monitoring sensor.

[0066] A third aspect of the present disclosure relates to a blood ketone sensor.

[0067] A fourth aspect of the present disclosure relates to a monitoring device comprising a multi-analyte monitoring sensor and an electronic assembly.

[0068] Hereinafter, the multi-analyte monitoring sensor involved in the present disclosure will be described with reference to the accompanying drawings.

[0069] Figure 1 is a schematic diagram of a multi-analyte monitoring sensor according to an example of the present disclosure. In Figure 1 , the polymer membrane layer is magnified for clarity, and the size relationship between the structure of an actual product and the polymer membrane layer may not be consistent with the figure.

[0070] In this embodiment, the sensor 10 can be used to obtain physiological parameter information of the host. In some examples, the sensor 10 can be applied to the host, and the host can obtain its own physiological parameter information by applying the monitoring device 1 to itself. In some examples, the sensor 10 can be mounted on a body surface part such as the host's arm, back, abdomen, waist, leg, etc. where the sensor 10 can be partially implanted to monitor physiological parameters. In some examples, the sensor 10 can be used to be implanted subcutaneously in the host to obtain a sensing signal (e.g., a current signal). In some examples, when the sensor 10 is applied to the host, it can come into contact with tissue fluid or blood in the host's body to measure the level of analyte in the tissue fluid or blood.

[0071] In some examples, the sensor 10 includes a working electrode. In some examples, there may be multiple working electrodes, and each working electrode may be used to detect a different analyte. Thus, the sensor 10 is capable of monitoring multiple analytes.

[0072] In some examples, the second analyte can be different from the first analyte. Thus, the sensor 10 of the present disclosure is capable of detecting a variety of different analytes. In some examples, the working electrode can include a first working electrode 12 and a second working electrode 13, where the first working electrode 12 can be used to detect the first analyte and the second working electrode 13 can be used to detect the second analyte. Thus, the sensor 10 is capable of detecting two analytes.

[0073] In some examples, the first analyte may be any one of glucose, urea, uric acid, ketone bodies, creatinine, ethanol, and lactic acid. In some examples, the second analyte may be any one of glucose, urea, uric acid, ketone bodies, creatinine, ethanol, and lactic acid. Among them, ketone bodies (which may be referred to as ketones) are a collective term for acetoacetic acid, β-hydroxybutyric acid, and acetone, intermediate products of fatty acid oxidation and decomposition in the liver. In the present invention, the content of ketone bodies can be monitored by detecting any one of acetoacetic acid, β-hydroxybutyric acid, and acetone. Preferably, parameters related to ketone body levels can be obtained by monitoring β-hydroxybutyric acid in the host. That is, the second analyte may be β-hydroxybutyric acid (which may be referred to as β-BHB, β-hydroxybutyric acid, or hydroxybutyric acid).

[0074] In some examples, the first analyte can be any of glucose, β-hydroxybutyrate, lactate, ethanol, uric acid, urea, acetylcholine, amylase, bilirubin, cholesterol, chorionic gonadotropin, creatine kinase, creatine, creatinine, DNA, fructosamine, glutamine, hormones, ketone bodies, lactate, oxygen, peroxide, prostate-specific antigen, prothrombin, RNA, troponin, digitoxin, digoxin, theophylline, warfarin, or an antibiotic.

[0075] In some examples, the second analyte can be any of glucose, β-hydroxybutyrate, lactate, ethanol, uric acid, urea, acetylcholine, amylase, bilirubin, cholesterol, chorionic gonadotropin, creatine kinase, creatine, creatinine, DNA, fructosamine, glutamine, hormones, ketone bodies, lactate, oxygen, peroxide, prostate-specific antigen, prothrombin, RNA, troponin, digitoxin, digoxin, theophylline, warfarin, or an antibiotic.

[0076] In some examples, the first analyte may be glucose. Thus, the glucose concentration in the body can be monitored. In some examples, the second analyte may be ketone bodies. Thus, the ketone body content in the body can be monitored. It should be noted that, as described above, ketone bodies are a collective term for acetoacetate, β-hydroxybutyrate, and acetone, intermediate products of fatty acid oxidation and decomposition in the liver. Therefore, the second analyte may be any one of acetoacetate, β-hydroxybutyrate, and acetone. Preferably, the second analyte may be β-hydroxybutyrate.

[0077] Hereinafter, the sensor 10 involved in the present disclosure will be described in detail by taking the case where the first analyte is glucose and the second analyte is ketone as an example.

[0078] In some examples, the sensor 10 may include an enzyme sensing layer disposed on a working electrode. In an example where the working electrode includes a first working electrode 12 and a second working electrode 13, the enzyme sensing layer may include a first analyte enzyme layer 121 and a second analyte enzyme layer 131 (see FIG1 ). The first analyte enzyme layer 121 may be disposed on the first working electrode 12, and the second analyte enzyme layer 131 may be disposed on the second working electrode 13. In this case, by disposing two analyte enzyme layers on the two working electrodes of the sensor 10, the concentration levels of two different analytes in the tissue fluid can be detected separately.

[0079] In some examples, the sensor 10 may include a polymer film layer 14 (see FIG1 ). The polymer film layer 14 may be configured to be permeable to the first analyte and the second analyte and to cover the first analyte enzyme layer 121 and the second analyte enzyme layer 131. In this case, the polymer film layer 14 can limit the permeability of the two analytes, while also helping to improve the stability of the sensor. In addition, due to the small size of the biosensor, when processing the sensor, if different semipermeable membranes need to be coated on different analyte electrodes, the precision requirements for the coating process will be very high. Compared to the solution of setting different semipermeable membranes on the first analyte enzyme layer 121 and the second analyte enzyme layer 131, the polymer film layer 14 in the present invention can simultaneously pass through the two analytes, thereby simplifying the manufacturing process of the sensor while maintaining the high sensitivity and accuracy of the sensor. Thus, a sensor 10 with a simple manufacturing process and capable of monitoring multiple analytes at the same time can be provided.

[0080] In some examples, the polymer film layer 14 is capable of simultaneously permeating glucose and ketones. In this case, by covering the first analyte enzyme layer 121 and the second analyte enzyme layer 131 with the polymer film layer 14, the permeability of the two analytes can be restricted, while also improving the stability of the sensor. In addition, due to the small size of the biosensor 10, the precision of the coating on the surface of the sensor 10 is required to be high. Typically, a dip-pull method is used to cover the surface of the sensor 10 with a membrane liquid to form a membrane layer covering the sensor 10. Compared to the solution of providing a semipermeable membrane that is permeable to glucose and ketones on the first analyte enzyme layer 121 and the second analyte enzyme layer 131, respectively, the polymer film layer 14 in the present invention is capable of simultaneously permeating glucose and ketones, thereby simplifying the manufacturing process of the sensor 10 while maintaining the high sensitivity and accuracy of the sensor 10. Thus, a sensor 10 with a simple manufacturing process and capable of continuous monitoring of glucose and ketones can be provided.

[0081] In some examples, the polymer film layer 14 may have a permeability coefficient for a first analyte of 1 to 1000. In some examples, the polymer film layer 14 may have a permeability coefficient for glucose of 1 to 1000. Preferably, the polymer film layer 14 may have a permeability coefficient for glucose of 300 to 800. For example, the polymer film layer 14 may have a permeability coefficient for glucose of 300, 400, 500, 600, 700, or 800. In some examples, the polymer film layer 14 may have a permeability coefficient for a second analyte of 1 to 1000. In some examples, the polymer film layer 14 may have a permeability coefficient for ketones of 1 to 1000. Preferably, the polymer film layer 14 may have a permeability coefficient for ketones of 200 to 600. For example, the polymer film layer 14 may have a permeability coefficient for ketones of 200, 300, 400, 500, or 600. The permeability coefficient refers to the difference in concentration between the inside and outside of the polymer membrane layer. For example, if the permeability coefficient of the polymer membrane layer for glucose is 500, the concentration of glucose outside the polymer membrane layer is 500 times that of glucose inside the polymer membrane layer.

[0082] In some examples, the thickness ratio of the polymer film layer 14 can be adjusted to provide the polymer film layer 14 with different permeability coefficients. In this case, by adjusting the permeability coefficient of the polymer film layer 14, the amount of analyte that passes through can be controlled, making the current generated by the working electrode more accurate, thereby making the sensor 10 more sensitive.

[0083] Figure 2A is a schematic diagram showing the front side of a multi-analyte monitoring sensor according to an example of the present disclosure. Figure 2B is a schematic diagram showing the back side of a multi-analyte monitoring sensor according to an example of the present disclosure.

[0084] In some examples, the sensor 10 can be used in conjunction with an electronic system, and the sensor 10 and the electronic system together constitute a sensing assembly (the sensing assembly may also be referred to as a monitoring device). Specifically, the sensor 10 can be electrically connected to the electronic system, and the sensor 10 can be partially implanted subcutaneously in the host to obtain a sensing signal indicating the level of the analyte, and then transmit the sensing signal to the electronic system; the electronic system can process and / or retransmit the sensing signal. In this case, the analyte concentration in the body can be accurately obtained. Therefore, the present disclosure can also provide a monitoring device, which includes the sensor 10 and the electronic system involved in the present disclosure.

[0085] In some examples, sensor 10 may include substrate 11 (see FIG. 1 ). Electrodes of sensor 10 may be disposed on substrate 11 .

[0086] In some examples, the sensor 10 may further include a reference electrode 15 and a counter electrode 16 (see Figures 2A and 2B). In this case, a four-electrode dual-path detection sensor can be formed, i.e., the first working electrode 12, the reference electrode 15, and the counter electrode 16 can form a three-electrode circuit, and the second working electrode 13, the reference electrode 15, and the counter electrode 16 can also form a three-electrode circuit.

[0087] In some examples, a four-electrode, two-way detection sensor may include a first working electrode 12, a second working electrode 13, a reference electrode 15, and a counter electrode 16. The first working electrode 12 forms a first loop with the reference electrode 15 and the counter electrode 16, and the second working electrode 13 forms a second loop with the reference electrode 15 and the counter electrode 16. In this case, the number of electrodes in the sensor can be reduced, thereby reducing the length of the substrate and, in turn, the implantation depth of the sensor 10. Since a deeper implantation produces more noticeable pain, this can reduce the pain of sensor 10 implantation and improve wearing comfort.

[0088] In some examples, the first working electrode 12 and the second working electrode 13 can be respectively located on both sides of the substrate 11, and the reference electrode 15 and the counter electrode 16 are respectively located on both sides of the substrate 11. In this case, arranging the four electrodes in pairs on both sides of the substrate can improve the utilization of the substrate, while optimizing the voltage drop of the sensor electrodes, reducing errors, and further reducing the interference of the electric field on the sensor system. In some examples, since the wearing comfort is related to the implantation depth, the greater the implantation depth, the greater the wearing pain may be. Therefore, arranging the four electrodes in pairs on both sides of the substrate can improve the utilization of the substrate. Arranging four electrodes in a limited substrate space can reduce the length of the substrate, thereby improving the wearing comfort.

[0089] In some examples, first working electrode 12 and second working electrode 13 can be located on the same side of substrate 11, and reference electrode 15 and counter electrode 16 can be located on the other side of substrate 11. In some examples, first working electrode 12, second working electrode 13, and reference electrode 15 can be located on the same side of substrate 11, and counter electrode 16 can be located on the other side of substrate 11. In some examples, first working electrode 12, second working electrode 13, and reference electrode 15 can be stacked sequentially on substrate 11. In some examples, the electrodes are separated by an insulating layer, and the first working electrode 12, second working electrode 13, and reference electrode 15 do not completely cover the previous electrode.

[0090] In some examples, the reference electrode 15 can form a known and fixed potential difference with the tissue fluid or blood. In this case, the potential difference between the working electrode and the tissue fluid or blood can be measured by the potential difference formed by the reference electrode 15 and the working electrode. As a result, the voltage generated by the working electrode can be obtained more accurately, and the electronic system can automatically adjust and maintain the stability of the voltage at the working electrode according to the preset voltage value, so that the measured current signal can more accurately reflect the analyte concentration level information in the tissue fluid or blood. In some examples, the number of reference electrodes 15 can be one or more, for example, two. In this case, the number of reference electrodes can be adjusted according to the number of working electrodes or the current generated by the working electrodes, so that an accurate current signal can be obtained, thereby improving the sensitivity of the sensor.

[0091] In some examples, the sensor 10 can be divided into an implant portion and a connection portion. The implant portion can be placed under the skin of the host and connected to the electronic system through the connection portion. In this case, by placing the implant portion under the skin of the host and electrically connecting the implant portion to the electronic system through the connection portion, it is possible to facilitate the transmission of the sensing signal obtained by the implant portion to the electronic system. In some examples, the implant portion can be rigid. Thus, it can help to be placed under the skin of the host. In other examples, the implant portion can also be flexible, in which case, the host's foreign body sensation can be reduced. In some examples, the polymer film layer 14 can cover the implant portion of the sensor 10. Thus, it can help to improve the biosafety of the implant portion.

[0092] In some examples, as described above, the sensor 10 may include a first analyte enzyme layer 121. In this case, the first analyte can react in the first analyte enzyme layer 121 to generate a current, and a concentration signal of the first analyte can be obtained.

[0093] In some examples, the first analyte enzyme layer 121 may include glucosidase. Thus, glucose can react in the first analyte enzyme layer, thereby generating a glucose concentration signal. In some examples, in the first analyte enzyme layer 121, the content (mass fraction) of glucosidase can be 40% to 70%. For example, the content (mass fraction) of glucosidase can be 40%, 41%, 42%, 43%, 44%, 45%, 46%, 47%, 48%, 49%, 50%, 51%, 52%, 53%, 54%, 55%, 56%, 57%, 58%, 59%, 60%, 61%, 61%, 62%, 63%, 64%, 65%, 66%, 67%, 68%, 69%, or 70%. Thus, it is possible to facilitate the reaction of glucose.

[0094] In some examples, the first analyte enzyme layer 121 can include an electron mediator. In some examples, the electron mediator can be a redox polymer. In some examples, the redox polymer can be a metal redox polymer. In some examples, the metal redox polymer can be selected from at least one of poly(vinylferrocene), quaternized poly(4-vinylpyridine) of ferricyanide, quaternized poly(1-vinylimidazole) of ferricyanide, quaternized poly(4-vinylpyridine) of ferrocyanide, quaternized poly(1-vinylimidazole) of ferrocyanide, quaternized poly(1-vinylimidazole) of ferrocyanide, an osmium 2,2'-bipyridine complex coordinated to poly(1-vinylimidazole), an osmium 2,2'-bipyridine complex coordinated to poly(4-vinylpyridine), a ruthenium 2,2'-bipyridine complex coordinated to poly(1-vinylimidazole), a ruthenium 2,2'-bipyridine complex coordinated to poly(4-vinylpyridine), a cobalt 2,2'-bipyridine complex coordinated to poly(1-vinylimidazole), or a cobalt 2,2'-bipyridine complex coordinated to poly(4-vinylpyridine). Thus, metal redox polymers can participate in redox reactions via covalent, coordinate, or ionic bonds.

[0095] In some examples, the content (mass fraction) of the electron mediator in the first analyte enzyme layer 121 can be 10% to 40%. For example, the content (mass fraction) of the electron mediator can be 10%, 11%, 12%, 13%, 14%, 15%, 16%, 17%, 18%, 19%, 20%, 21%, 22%, 25%, 26%, 27%, 28%, 29%, 30%, 31%, 32%, 33%, 34%, 35%, 36%, 37%, 38%, 39%, or 40%. Thus, the reaction of the first analyte in the first analyte enzyme layer can be promoted.

[0096] In some examples, the first analyte enzyme layer 121 may include a crosslinker. In some examples, the crosslinker may be PEGDGE. In some examples, the crosslinker may be PEGDGE400. In some examples, the content (mass fraction) of the crosslinker in the first analyte enzyme layer 121 may be 0% to 20%. For example, the content (mass fraction) of the crosslinker may be 0%, 1%, 2%, 3%, 4%, 5%, 6%, 7%, 8%, 9%, 10%, 11%, 12%, 13%, 14%, 15%, 16%, 17%, 18%, 19%, or 20%. This facilitates long-term monitoring by the sensor.

[0097] In some examples, the sensitivity of the first working electrode 12 differs from the sensitivity of the second working electrode 13 by no more than 6 times. "The sensitivity difference is no more than 6 times" means that, assuming the sensitivity of the first working electrode 12 is X, the sensitivity of the second working electrode 13 is no less than X / 6 and no more than 6X. In this case, on the one hand, it can help reduce the current difference between the two working electrodes and reduce the interference of the electric field on the sensor system; on the other hand, if the sensitivity difference between the two analyte electrodes is too large, the reaction amount of the analyte at the high-sensitivity electrode may be large, thereby affecting the reaction between the low-sensitivity electrode and the analyte. Setting the sensitivity of the two electrodes to no more than 6 times can also suppress this situation, thereby helping to improve the measurement accuracy of the sensor 10.

[0098] In some examples, preferably, the sensitivity of first working electrode 12 differs from the sensitivity of second working electrode 13 by no more than a factor of 3. This can help reduce the current difference between the two working electrodes. In some examples, the ratio of the sensitivity of first working electrode 12 to the sensitivity of second working electrode 13 can be 6:1, 5:1, 4:1, 3:1, 2:1, 1:1, 1:2, 1:3, 1:4, 1:5, or 1:6.

[0099] In some examples, the area of ​​the first analyte enzyme layer 121 can be larger or smaller than the area of ​​the second analyte enzyme layer 131. Since the amounts of the two analytes that can pass through the polymer membrane layer 14 are different, the area of ​​the first analyte enzyme layer 121 can be set to be larger or smaller than the area of ​​the second analyte enzyme layer 131. This allows for selecting an appropriate solution based on the amount of the two analytes that can pass through the polymer membrane layer 14. For example, when the amount of the first analyte that can pass through the polymer membrane layer 14 is smaller than the amount of the second analyte, by configuring the area of ​​the first analyte enzyme layer 121 to be larger than the area of ​​the second analyte enzyme layer 131, the contact area between the first analyte enzyme layer 121 and the first analyte can be increased, thereby minimizing the current difference between the two working electrodes, helping to keep the current magnitudes on the two working electrodes at the same level, reducing interference of the electric field on the sensor system, and further improving the measurement accuracy of the sensor 10.

[0100] In some examples, the area of ​​the first analyte enzyme layer 121 can be larger than the area of ​​the second analyte enzyme layer 131. Since the polymer membrane layer 14 can transmit different amounts of glucose and ketones, and generally the amount of glucose is less than the amount of ketones, in this case, by configuring the area of ​​the first analyte enzyme layer 121 to be larger than the area of ​​the second analyte enzyme layer 131, the contact area between the first analyte enzyme layer 121 and glucose can be increased, thereby minimizing the current difference between the two working electrodes, ensuring that the currents on the two working electrodes are at the same level, reducing the interference of the electric field on the sensor 10 system, and further improving the measurement accuracy of the sensor 10.

[0101] In some examples, the area ratio of the first analyte enzyme layer 121 to the second analyte enzyme layer 131 can be greater than 1:1. This can help improve the sensitivity of the sensor 10. In some examples, the area ratio of the first analyte enzyme layer 121 to the second analyte enzyme layer 131 can be less than 1.5:1. This can improve the accuracy of the sensor 10. In some examples, the area ratio of the first analyte enzyme layer 121 to the second analyte enzyme layer 131 can be between 1:1 and 1.5:1. This can improve the reaction sensitivity of the first analyte and accurately reflect the concentration level of the analyte in the tissue fluid. In some examples, the area ratio of the second analyte enzyme layer 131 to the first analyte enzyme layer 121 can be 1:1.5, 1:1.4, 1:1.3, 1:1.2, or 1:1.1. This can more accurately reflect the concentration level of the analyte in the tissue fluid.

[0102] In some examples, the area of ​​the first analyte enzyme layer 121 may also be equal to the area of ​​the second analyte enzyme layer 131. In this example, if there is a significant difference in sensitivity between the two analyte working electrodes, other methods can be used for adjustment, such as adjusting the component or composition of the polymer membrane layer 14 to achieve the desired effect (described in detail later).

[0103] In some examples, the first analyte enzyme layer 121 and / or the second analyte enzyme layer 131 can be linear. This can improve the utilization rate of the substrate and at the same time enhance the sensitivity of the sensor. Due to the limitations of existing processing levels and the small size of the sensor, when a very small analyte enzyme layer is applied to the working electrode of the sensor, it is difficult to directly apply a uniform linear enzyme layer on the electrode surface with the existing processing precision. In some examples of the present disclosure, the enzyme layer solution can be applied to the working electrode by drop coating. The drop-shaped solution applied to the working electrode can diffuse and connect to form a whole linear solution. In this case, compared to the solution of multi-point discrete arrangement, a larger area of ​​enzyme layer can be arranged on the working electrode with a limited area, thereby improving the sensitivity of the sensor 10. In some examples, two adjacent droplets of solution can intersect during drop coating, thereby forming a linear analyte enzyme layer on the working electrode by connecting multiple points into a line. In this case, the multi-point line connection method can reduce the processing difficulty of the sensor 10, thereby forming a linear analyte enzyme layer, and thus improving the utilization rate of the substrate.

[0104] In the present disclosure, "the first analyte enzyme layer 121 and / or the second analyte enzyme layer 131 are linear" can include at least three embodiments: the first analyte enzyme layer 121 is linear, the second analyte enzyme layer 131 is linear, and the first analyte enzyme layer 121 and the second analyte enzyme layer 131 are linear. In the present disclosure, other expressions of "A and / or B" have the same meaning as the above-mentioned examples. In this case, by adjusting the area of ​​the analyte enzyme layer, it can be beneficial to improve the sensitivity and accuracy of the sensor 10 when monitoring two analytes.

[0105] Fig. 3 is a schematic diagram showing the polymer membrane layer 14 according to an example of the present disclosure. In Fig. 3 , the illustration of the analyte enzyme layer is omitted.

[0106] In some examples, the first working electrode 12 may include a base layer 140. This can improve the stability of the sensor 10. In some examples, the base layer 140 is conductive, thereby conducting the current signal generated by the analyte reaction. In some examples, the base layer 140 may be made of at least one material selected from gold, glassy carbon, graphite, silver, silver chloride, palladium, titanium, and iridium. In this case, the base layer 140 can have good conductivity and can inhibit electrochemical reactions in the base layer 140, thereby improving the stability of the base layer 140.

[0107] In some examples, the polymer film layer 14 may cover the base layer 140 of the working electrode (see FIG3 ), thereby simplifying the film manufacturing process of the sensor 10 and improving the biocompatibility of the sensor 10 , thereby facilitating long-term use of the sensor 10 .

[0108] In some examples, the polymer film layer 14 may include a membrane polymer. In some examples, the membrane polymer may be a vinyl pyridine polymer, polyurethane, sodium polystyrene sulfonate, poly(N-isopropylacrylamide), polyacrylic acid, polyvinyl alcohol, polyvinyl pyrrolidone, poly(oligo(ethylene glycol) methyl ether methyl methacrylate), or a block copolymer or blend thereof. This facilitates the formation of a polymer film layer 14 that has a permeation-limiting effect on the two analytes and is biocompatible. The polymer film layer 14 can help control the amount of the analytes within the linear range of the sensor 10, thereby improving the sensitivity and accuracy of the sensor 10.

[0109] In some examples, the mass fraction of the membrane polymer in the polymer membrane layer 14 can be 80% to 100%. This facilitates the formation of a polymer membrane layer 14 that has a permeation-restricting effect on both analytes and is biocompatible. The polymer membrane layer 14 can help control the amount of the analytes within the linear range of the sensor 10, thereby improving the sensitivity and accuracy of the sensor 10. In some examples, the polymer membrane layer 14 can preferably include a vinylpyridine polymer. This facilitates the formation of a polymer membrane layer 14 that has a permeation-restricting effect on glucose and ketones. In some examples, the mass fraction of the vinylpyridine polymer in the polymer membrane layer 14 can preferably be 80% to 100%. This facilitates the formation of a polymer membrane layer 14 that has a permeation-restricting effect on glucose and ketones and is biocompatible. The polymer membrane can control the amount of glucose and ketones within the linear range of the sensor, thereby improving the sensitivity and accuracy of the sensor. In some examples, the mass fraction of the vinylpyridine polymer in the polymer film layer 14 is 80%, 81%, 82%, 83%, 84%, 85%, 86%, 87%, 88%, 89%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, 99%, or 100%. This facilitates forming a stable polymer film layer 14 and improving the permeation restriction effect of the polymer film layer 14 on glucose and ketones.

[0110] In some examples, the polymer film layer 14 may be biocompatible, thereby helping to improve the safety performance of the sensor 10 .

[0111] In some examples, the polymer film layer 14 may further include a crosslinker and a modifier. In some examples, the crosslinker may be polyethylene glycol diglycidyl ether (PEGDGE). This can enhance the stability of the polymer film layer 14 and, in turn, improve the performance of the sensor 10. In some examples, the modifier may be polydimethylsiloxane (PDMS). In this case, the modifier can reduce the surface tension of the entire film layer, helping to form a uniform film layer and improving the consistency of the sensor 10.

[0112] In some examples, the polymer film layer 14 may include a first film layer 141. The first film layer 141 may be disposed peripherally to the enzyme sensing layer. This can limit the permeation of analytes in the tissue fluid while preventing the permeation of other interfering substances, thereby improving the reaction efficiency of the enzyme sensing layer and, in turn, the sensitivity and stability of the sensor. In some examples, the first film layer 141 may have a diffusion-limiting effect on the first and second analytes. In the present disclosure, the first film layer 141 may also be referred to as a diffusion-limiting layer. In some examples, the first film layer 141 may be biocompatible.

[0113] In some examples, the polymer film layer 14 may include a second film layer 143. The second film layer 143 may be biocompatible. This can reduce the occurrence of inflammation caused by the sensor 10 being implanted in the body. In some examples, the second film layer 143 may be disposed on the first film layer 141. In this case, a polymer film layer 14 having a permeation-limiting effect and a biocompatible effect can be formed, which in turn helps to improve the sensitivity and stability of the sensor 10. In some examples, the second film layer 143 may be further away from the enzyme sensing layer than the first film layer 141. That is, the second film layer 143 may be disposed on the periphery of the first film layer 141. In the present disclosure, the second film layer 143 may also be referred to as a biocompatible layer.

[0114] In some examples, the polymer film layer 14 may include a negatively charged film layer that has a diffusion-restricting effect on the first analyte and the second analyte. In this case, the negatively charged film layer has a certain repulsive effect on negatively charged substances, and therefore can have a stronger diffusion-restricting effect on negatively charged analytes. When the first analyte and the second analyte are a neutral molecule and a negatively charged molecule, respectively, and the permeability of the negatively charged molecule is larger, providing a negatively charged film layer can help reduce the difference in permeability between the two analytes, thereby minimizing the current difference between the two working electrodes and improving the measurement accuracy of the sensor. For example, when the first analyte is glucose and the second analyte is β-hydroxybutyrate, since the glucose molecule is a neutral molecule and β-hydroxybutyrate is a negatively charged molecule, and the permeability of β-hydroxybutyrate is larger than that of glucose, in this case, providing a negatively charged film layer can help reduce the difference in permeability between glucose and β-hydroxybutyrate.

[0115] In some examples, the polymer film layer 14 may further include a transition layer. The transition layer may be disposed between the first film layer 141 and the second film layer 143. This allows for a stable polymer film layer 14. Specifically, in some examples, the polymer film layer 14 may include a first film layer 141 disposed sequentially on the enzyme sensing layer, a transition layer formed on the first film layer 141, and a biocompatible second film layer 143 formed on the transition layer. This improves the bonding stability of the polymer film layer 14, thereby enhancing the stability of the sensor 10.

[0116] In some examples, the first film layer 141 may include a first type of polymer. In some examples, the first type of polymer may include a water-swellable homopolymer. This can facilitate the first film layer. In some examples, the water-swellable homopolymer may be selected from polystyrene, polyurethane, polyethoxyethyl acrylate, polyethoxypropyl acrylate, poly-2-vinylpyridine, poly-4-vinylpyridine, polyhydroxyethyl methacrylate, and polyhydroxyethyl acrylate. This can create a diffusion-controlled polymer layer, resulting in a fixed analyte concentration ratio on both sides of the polymer film layer, thereby expanding the linear response range of the biosensor.

[0117] In some examples, the first polymer can be modified by grafting biocompatible functional groups to improve its biocompatibility. For example, by grafting biocompatible functional groups onto poly-4-vinylpyridine, the biocompatibility of the material can be improved. Furthermore, because the first polymer backbone is hydrophobic while retaining a certain diffusion restriction effect, further adjusting the grafting ratio can allow the first film layer 141 to simultaneously possess both diffusion restriction and biocompatibility.

[0118] In some examples, first film layer 141 may be a negatively charged film layer. In some examples, the first type of polymer may include negatively charged groups. This can facilitate the formation of first film layer 141 that carries negative ions. In some examples, the negatively charged groups may be selected from one or more of sulfonic acid groups and carboxyl groups. In other words, the first type of polymer may include sulfonic acid groups and / or carboxyl groups.

[0119] In some examples, the first type of polymer can be selected from vinyl pyridine polymers, polyurethane, sodium polystyrene sulfonate, poly(N-isopropylacrylamide), polyacrylic acid, polyvinyl alcohol, polyvinyl pyrrolidone, poly(oligo(ethylene glycol) methyl ether methyl methacrylate), or block copolymers or blends of the above polymers. This can facilitate the formation of a first membrane layer 141 that has a permeation-restricting effect on two analytes and is biocompatible. The first membrane layer 141 can help control the amount of the analyte within the linear range of the sensor 10, thereby improving the sensitivity and accuracy of the sensor 10. In some examples, the first membrane layer 141 can preferably include a vinyl pyridine polymer. This can form a membrane layer that has a permeation-restricting effect on two analytes.

[0120] In some examples, the first film layer 141 can be formed from a first film liquid. Specifically, the first film liquid can be applied to a predetermined location to form the first film layer 141. In some examples, the concentration of the first type of polymer in the first film liquid can be between 1 mg / mL and 150 mg / mL. For example, the concentration of the first type of polymer in the first film liquid can be 1 mg / mL, 10 mg / mL, 20 mg / mL, 30 mg / mL, 40 mg / mL, 50 mg / mL, 60 mg / mL, 70 mg / mL, 80 mg / mL, 90 mg / mL, 100 mg / mL, 110 mg / mL, 120 mg / mL, 130 mg / mL, 140 mg / mL, or 150 mg / mL. In some examples, the concentration of the first type of polymer in the first film liquid can be between 20 mg / mL and 80 mg / mL. Because lower solute concentrations in the film liquid within a certain range result in lower viscosity, selecting an appropriate concentration can improve the uniformity of the formed film layer within a certain range.

[0121] In some examples, the second film layer 143 may include a second type of polymer. In some examples, the second type of polymer may include a water-soluble polymer. In some examples, the water-soluble polymer may be selected from polyvinyl pyrrolidone, polyvinyl alcohol, polyvinyl pyrrolidone, chitosan, carboxymethyl chitosan, chitosan salt, alginic acid, alginate, hyaluronic acid, hyaluronate, cellulose ethers, cellulose esters, polyvinyl pyrrolidone, polyacrylamide, polyacrylic acid, polypropylene alcohol, sodium polystyrene sulfonate, polyethylene glycol, and polyethylene glycol-polypropylene glycol copolymer. Thus, the biocompatibility of the biosensor can be improved.

[0122] In some examples, preferably, the second film layer 143 may include a copolymer of vinyl pyridine and styrene, thereby improving the film-forming performance of the polymer film layer 14 and further enhancing the sensitivity of the sensor 10 .

[0123] In some examples, the second film layer 143 can be formed from a second film liquid. Specifically, the first film liquid can be applied to a predetermined location to form the second film layer 143. In some examples, the concentration of the second type of polymer in the second film liquid can be 1 mg / mL to 150 mg / mL. In some examples, for example, the concentration of the second type of polymer in the second film liquid can be 1 mg / mL, 10 mg / mL, 20 mg / mL, 30 mg / mL, 40 mg / mL, 50 mg / mL, 60 mg / mL, 70 mg / mL, 80 mg / mL, 90 mg / mL, 100 mg / mL, 110 mg / mL, 120 mg / mL, 130 mg / mL, 140 mg / mL, or 150 mg / mL. In some examples, the concentration of the second type of polymer in the second film liquid can be 20 mg / mL to 80 mg / mL. Because lower solute concentrations in the film liquid within a certain range result in lower viscosity, selecting an appropriate concentration can improve the uniformity of the formed film layer within a certain range.

[0124] In some examples, the transition layer can include a third polymer. The third polymer is a copolymer formed from a first monomer identical to or similar to the first polymer and a second monomer identical to or similar to the second polymer. This can improve the bonding stability and mechanical strength of the polymer film layer 14, thereby enhancing the stability of the sensor 10. This creates a transition layer with enhanced adhesion to the first film layer 141 and the second film layer 143, facilitating the formation of the polymer film layer 14. This, in turn, can help expand the linear response range of the sensor 10 and improve its biocompatibility.

[0125] In some examples, the transition layer may include a copolymer of vinyl pyridine and styrene, thereby facilitating the formation of a uniform and stable polymer film layer 14 and thereby improving the stability of the polymer film layer.

[0126] In some examples, the analyte enzyme in first analyte enzyme layer 121 and second analyte enzyme layer 131 can be selected based on the type of analyte. For example, when the second analyte is lactate, second analyte enzyme layer 131 can include lactate oxidase. In some examples, the analyte enzyme in second analyte enzyme layer 131 can be 10% to 35%.

[0127] In some examples, when the second analyte is β-hydroxybutyrate, the second analyte enzyme layer 131 may include hydroxybutyrate dehydrogenase. In this case, hydroxybutyrate in the tissue fluid can react with the hydroxybutyrate dehydrogenase, thereby generating a signal to determine the concentration of hydroxybutyrate. The concentration of ketone bodies in the tissue fluid can then be mapped to the hydroxybutyrate concentration. In some examples, the hydroxybutyrate dehydrogenase content in the second analyte enzyme layer 131 may be between 10% and 30%. For example, the hydroxybutyrate dehydrogenase content may be 10%, 11%, 12%, 13%, 14%, 15%, 16%, 17%, 18%, 19%, 20%, 21%, 22%, 23%, 24%, 25%, 26%, 27%, 28%, 29%, 30%, 31%, 32%, 33%, 34%, or 35%. This can help promote the redox reaction of β-hydroxybutyrate in the second analyte enzyme layer 131 .

[0128] In some examples, the second analyte enzyme layer 131 may include albumin, thereby helping to improve the stability of the second analyte enzyme layer 131. In some examples, the second analyte enzyme layer 131 may include human serum albumin.

[0129] In some examples, the second analyte enzyme layer 131 may include diaphorase. In this case, the diaphorase can transfer electrons generated by the β-BHB reaction. In some examples, the diaphorase content in the second analyte enzyme layer 131 may be 5% to 40%. For example, the diaphorase content may be 5%, 6%, 7%, 8%, 9%, 10%, 11%, 12%, 13%, 14%, 15%, 16%, 17%, 18%, 19%, 20%, 21%, 22%, 23%, 24%, 25%, 26%, 27%, 28%, 29%, 30%, 31%, 32%, 33%, 34%, 35%, 36%, 37%, 38%, 39%, or 40%. This can promote the reaction of the second analyte enzyme layer 131 and improve the efficiency of electron transfer in the working electrode.

[0130] In some examples, the second analyte enzyme layer 131 may include a coenzyme. This can promote the oxidation of hydroxybutyrate dehydrogenase, thereby transferring electrons generated by the β-BHB reaction. In some examples, the coenzyme can be nicotinamide adenine dinucleotide (NAD+). In some examples, the content of the coenzyme in the second analyte enzyme layer 131 can be 10% to 45%. For example, the content of the coenzyme can be 10%, 12%, 14%, 15%, 16%, 18%, 19%, 20%, 21%, 22%, 25%, 26%, 27%, 28%, 29%, 30%, 31%, 32%, 33%, 34%, 35%, 36%, 37%, 38%, 39%, 40%, 41%, 42%, 43%, 44%, or 45%. This can promote the redox reaction between hydroxybutyrate dehydrogenase and β-BHB.

[0131] In some examples, the second analyte enzyme layer 131 can include an electron mediator. In some examples, the electron mediator can be a redox polymer. In some examples, the redox polymer can be a metal redox polymer. In some examples, the metal redox polymer can be selected from at least one of poly(vinylferrocene), quaternized poly(4-vinylpyridine) of ferricyanide, quaternized poly(1-vinylimidazole) of ferricyanide, quaternized poly(4-vinylpyridine) of ferrocyanide, quaternized poly(1-vinylimidazole) of ferrocyanide, quaternized poly(1-vinylimidazole) of ferrocyanide, an osmium 2,2'-bipyridine complex coordinated to poly(1-vinylimidazole), an osmium 2,2'-bipyridine complex coordinated to poly(4-vinylpyridine), a ruthenium 2,2'-bipyridine complex coordinated to poly(1-vinylimidazole), a ruthenium 2,2'-bipyridine complex coordinated to poly(4-vinylpyridine), a cobalt 2,2'-bipyridine complex coordinated to poly(1-vinylimidazole), or a cobalt 2,2'-bipyridine complex coordinated to poly(4-vinylpyridine). Thus, the metal redox polymer can participate in the redox reaction through covalent bonds, coordination bonds or ionic bonds, and can promote the transfer of electrons to the working electrode, thereby generating a current signal of the second analyte concentration.

[0132] In some examples, the electron mediator content in the second analyte enzyme layer 131 may be 10% to 50%. For example, the electron mediator content may be 10%, 12%, 14%, 15%, 16%, 18%, 19%, 20%, 21%, 22%, 25%, 26%, 27%, 28%, 29%, 30%, 31%, 32%, 33%, 34%, 35%, 36%, 37%, 38%, 39%, 40%, 41%, 42%, 43%, 44%, 45%, 46%, 47%, 48%, 49%, or 50%. In this case, the sensitivity of the second analyte enzyme layer 131 to β-BHB can be improved. At the same time, by providing a macromolecular electron mediator in the enzyme layer, the hydroxybutyrate dehydrogenase can be covalently bound to the electron mediator, thereby further improving stability.

[0133] According to the first aspect of the present disclosure, a multi-analyte monitoring sensor can be provided, which can continuously monitor multiple analytes simultaneously, has a simple manufacturing process, and has high sensitivity and stability.

[0134] The second aspect of the present disclosure relates to a semipermeable membrane for a multi-analyte monitoring sensor. The semipermeable membrane of the multi-analyte monitoring sensor of the second aspect of the present disclosure is consistent with the polymer membrane layer 14 of the sensor 10 of the first aspect of the present disclosure. The structure of the polymer membrane layer 14, the configuration of its various components and parameters, and the preparation method thereof can be found in the description above and will not be repeated here.

[0135] In the second aspect of the present disclosure, a semipermeable membrane with high stability and capable of limiting the permeation of both glucose and ketones can be provided. The semipermeable membrane covering the electrodes of the multi-analyte sensor 10 can help improve the sensitivity of the sensor 10.

[0136] The third aspect of the present disclosure relates to a blood ketone sensor. The blood ketone sensor involved in the third aspect of the present disclosure is basically the same as the sensor 10 involved in the first aspect of the present disclosure, except that the first working electrode and the first analyte enzyme layer provided on the first working electrode are removed from the sensor 10 involved in the first aspect, and the second working electrode and the second analyte enzyme layer (i.e., the enzyme layer for detecting ketones) for analyzing ketones are retained. The other parts are consistent with the sensor 10 involved in the first aspect and are not repeated here. In some examples, in the blood ketone sensor, the second working electrode 13 and the reference electrode 15 can be provided on the same side of the substrate 11, and the counter electrode 16 can be provided on the other side of the substrate 11. In this way, the utilization rate of the substrate can be improved. The blood ketone sensor involved in the third aspect of the present disclosure can be used to measure the ketone body level in the host body.

[0137] A fourth aspect of the present disclosure relates to a monitoring device, comprising the sensor 10 of the first aspect of the present disclosure and an electronic system, wherein the electronic system can be electrically connected to the sensor 10. Thus, a monitoring device capable of monitoring multiple analytes can be provided.

[0138] Hereinafter, the multi-analyte monitoring sensor and the blood ketone sensor provided by the present disclosure will be described in detail with reference to the examples and comparative examples, but they should not be construed as limiting the scope of protection of the present disclosure.

[0139] [Blood glucose + blood ketone sensor]

[0140] Example 1

[0141] First, a monitoring probe with front and back dual working electrodes is prepared, namely a first working electrode and a second working electrode.

[0142] Next, prepare the ketone body sensitive layer reagent components (osmium coordinated metal polymer, β-hydroxybutyrate dehydrogenase, diaphorase, NAD + , stabilizer, cross-linking agent), dissolve each substance in a buffer solvent in a HEPES buffer according to the concentration parameters in the table to obtain a β-hydroxybutyrate sensitive layer solution.

[0143] Subsequently, a glucose-sensitive layer solution was prepared according to the concentration of osmium coordinated metal polymer of 10 mg / mL, glucose oxidase (GOD) of 12.5 mg / mL, and cross-linking agent PEGDGE of 2.5 mg / mL.

[0144] The glucose sensitive layer solution was deposited on the first working electrode, and the β-hydroxybutyrate sensitive layer solution was deposited on the second working electrode, forming a linear pattern. The glucose sensing layer had an area of ​​approximately 0.27 mm. 2 The ketone body sensing layer area is about 0.27mm 2 ; That is, the area ratio of blood ketone to blood glucose sensing layer is 1:1; solidification is performed to obtain an electrode containing a dual-component response sensing layer of glucose and ketone bodies.

[0145] Table 1. Ketone body sensitive layer reagent components

[0146] Then, ethanol was prepared as a solvent, and polyvinylpyridine and PEGDGE were prepared according to Table 2 to obtain a diffusion-limiting membrane solution. The diffusion-limiting membrane solution was applied to the electrode deposited with the sensitive layer reagent to prepare a dual-component monitoring working electrode with a membrane layer of approximately 25 μm.

[0147] Table 2. Diffusion-limiting membrane solution composition

[0148] Prepare an 80% ethanol aqueous solution, and mix poly (4-vinylpyridine-co-polystyrene) and PEGDGE at corresponding concentrations according to Table 3 to obtain a compatible membrane solution. Apply the compatible membrane solution to the diffusion-limiting membrane of the working electrode to produce a working electrode containing an approximately 15 μm compatible membrane layer.

[0149] Table 3. Compatibility membrane solution composition

[0150] Prepare an 80% ethanol aqueous solution, and prepare (poly (4-vinylpyridine-g-polyethylene glycol))-co-polystyrene and PEGDGE to corresponding concentrations according to Table 4 to obtain a biocompatible membrane solution; apply the biocompatible membrane solution to the compatible membrane of the working electrode to produce a biocompatible membrane layer containing approximately 15 microns, resulting in a working electrode with a total film thickness of approximately 56 microns.

[0151] Table 4. Biocompatible membrane solution composition

[0152] The sensor of Example 1 was immersed in a standard PBS buffer (pH 7.4) at 37°C. A working voltage was applied until a constant background current was reached, and the response current was measured simultaneously with corresponding concentrations of glucose / sodium β-hydroxybutyrate. The concentrations were as follows: 2.2mM / 1mM, 5mM / 2mM, 10mM / 3mM, 15mM / 4mM, 20mM / 6mM, and 25mM / 8mM, where the former represents the glucose concentration and the latter represents the sodium β-hydroxybutyrate concentration.

[0153] FIG4 is a graph showing the response current-test concentration curve of Example 1 of the blood glucose + blood ketone sensor of the present disclosure. As shown in FIG4 , the response of the dual-component sensor of Example 1 to glucose and sodium β-hydroxybutyrate exhibits good linearity. Specifically, it can be seen that the linear response current curve R 2 Both are greater than 0.996, indicating a good linear relationship. The sensitivity of the glucose working electrode is 0.79nA / mM, and the sensitivity of the ketone body working electrode is 2.35nA / mM.

[0154] Example 2

[0155] First, a monitoring probe with front and back dual working electrodes is prepared, namely a first working electrode and a second working electrode.

[0156] Next, a β-hydroxybutyrate sensitive layer solution and a glucose sensitive layer solution were prepared using the same formula as in Example 1, wherein the metal polymer was a ruthenium coordinated metal polymer. The glucose sensitive layer solution was deposited on the first working electrode, and the β-hydroxybutyrate sensitive layer solution was deposited on the second working electrode, each forming a linear pattern, wherein the glucose sensing layer had an area of ​​approximately 0.3 mm.2 The ketone body sensing layer area is about 0.27mm 2 ; solidification is performed to obtain an electrode containing a dual-component responsive sensing layer of glucose and ketone bodies.

[0157] The diffusion limiting membrane, the compatibility membrane and the biocompatible membrane were coated in the same manner as in Example 1 to obtain the sensor of Example 2 having a blood glucose to blood ketone sensing layer area ratio of 1.11:1.

[0158] FIG5 is a picture showing a monitoring probe of Example 2 of the blood glucose + blood ketone sensor according to the present disclosure.

[0159] The sensor of Example 2 was immersed in a standard PBS buffer (pH 7.4) at 37°C. A working voltage was applied until a constant background current was reached, and the response current was measured simultaneously with corresponding concentrations of glucose / sodium β-hydroxybutyrate. The concentrations were as follows: 2.2mM / 1mM, 5mM / 2mM, 10mM / 3mM, 15mM / 4mM, 20mM / 6mM, and 25mM / 8mM, where the former represents the glucose concentration and the latter represents the sodium β-hydroxybutyrate concentration.

[0160] FIG6 is a graph showing the response current versus test time of Example 2 of the blood glucose + blood ketone sensor according to the present disclosure. FIG7 is a graph showing the response current versus test concentration of Example 2 of the blood glucose + blood ketone sensor according to the present disclosure. As shown in FIG6 and FIG7 , the response of the dual-component sensor of Example 2 to glucose and sodium β-hydroxybutyrate exhibits good linearity. Specifically, as shown in FIG7 , the linear response current curve R of the sensor to glucose and sodium β-hydroxybutyrate is 2 Both were greater than 0.99, indicating a good linear relationship. The sensitivity of the glucose working electrode was 1.10 nA / mM, and the sensitivity of the ketone body working electrode was 2.43 nA / mM.

[0161] The sensor of Example 2 was immersed in standard PBS buffer (pH 7.4) at 37°C for 336 hours (14 days). FIG8 shows the glucose / sodium β-hydroxybutyrate response current-time curve of Example 2 of the blood glucose + blood ketone sensor of the present disclosure. As shown in FIG8 , both current signals of the sensor remained stable during the test period from day 0 to day 14.

[0162] Example 3

[0163] A monitoring probe with dual working electrodes was prepared in the same manner as in Example 1. The glucose sensitive layer solution was deposited on the first working electrode, and the β-hydroxybutyrate sensitive layer solution was deposited on the second working electrode, forming a linear pattern. The glucose sensing layer had an area of ​​approximately 0.39 mm. 2The ketone body sensing layer area is about 0.26mm 2 ; That is, the area ratio of blood ketone to blood glucose sensing layer is 1:1.5; solidification is performed to obtain an electrode containing a dual-component response sensing layer of glucose and ketone bodies.

[0164] Next, the diffusion limiting membrane, the compatibility membrane, and the biocompatible membrane were coated in the same manner as in Example 1 to obtain the sensor of Example 3 having a blood ketone to blood glucose sensing layer area ratio of 1:1.5.

[0165] The sensor of Example 3 was immersed in a standard PBS buffer (pH 7.4) at 37°C. A working voltage was applied until a constant background current was reached, and the response current was measured simultaneously with corresponding concentrations of glucose / sodium β-hydroxybutyrate. The concentrations were as follows: 2.2mM / 1mM, 5mM / 2mM, 10mM / 3mM, 15mM / 4mM, 20mM / 6mM, and 25mM / 8mM, where the former represents the glucose concentration and the latter represents the sodium β-hydroxybutyrate concentration.

[0166] FIG9 is a graph showing the response current-test concentration curve of Example 3 of the blood glucose + blood ketone sensor of the present disclosure. As shown in FIG9 , the response of the dual-component sensor of Example 3 to glucose and sodium β-hydroxybutyrate shows good linearity. Specifically, the linear response current curve R of the sensor to glucose and sodium β-hydroxybutyrate is 2 Both are greater than 0.997, indicating a good linear relationship. The sensitivity of the glucose working electrode is 1.22nA / mM, and the sensitivity of the ketone body working electrode is 2.52nA / mM.

[0167] Example 4-Example 7

[0168] First, a monitoring probe with front and back dual working electrodes is prepared, namely a first working electrode and a second working electrode.

[0169] Secondly, prepare the ketone body sensitive layer reagent raw materials (osmium coordinated metal polymer, β-hydroxybutyrate dehydrogenase, myocardial diaphoresis, NAD+, stabilizer, cross-linker, etc.) according to the table below, dissolve each substance in the corresponding solvent buffer solvent according to the concentration parameters in the table, and ultrasonically vibrate to completely dissolve it to obtain the β-hydroxybutyrate sensitive layer solution of Example 4-7.

[0170] Similarly, prepare the glucose-sensitive layer solution (osmium-coordinated metal polymer, glucose oxidase, cross-linking agent, etc.) according to the table below;

[0171] The glucose sensitive layer solution was deposited on the first working electrode, and the β-hydroxybutyrate sensitive layer solution was deposited on the second working electrode, forming a linear pattern. The glucose sensing layer area was about 0.3 mm. 2 The ketone body sensing layer area is about 0.3mm 2 ; solidification is performed to obtain an electrode containing a dual-component responsive sensing layer of glucose and ketone bodies.

[0172] Then, the electrodes with modified sensing layers were coated with the first and second membrane layers according to the following table by dipping and pulling, to obtain the sensors of Examples 4 to 7.

[0173] Figures 10 to 13 are pictures of the monitoring probes of the sensors of Examples 4 to 7. As can be seen from Figures 10 to 13, the morphology of the semipermeable membranes on each sensor is relatively uniform.

[0174] The sensors of Examples 4-7 were immersed in standard PBS buffer (pH 7.4) at 37°C. A working voltage was applied until a constant background current was reached, and the response current was measured in the presence of glucose and sodium β-hydroxybutyrate at corresponding concentrations. The concentrations were as follows: 2.2mM / 1mM, 5mM / 2mM, 10mM / 3mM, 15mM / 4mM, 20mM / 6mM, and 25mM / 8mM, with the former indicating glucose concentration and the latter indicating sodium β-hydroxybutyrate concentration. The measurement results for each example are shown in the table below:

[0175] Both Examples 4 and 5 use polyvinylpyridine as the diffusion limiting membrane and (poly-4-vinylpyridine-g-polyethylene glycol)-co-polystyrene as the biocompatible membrane. However, the PDMS concentration in the diffusion membrane layer components of Example 5 is higher, which can reduce the surface tension of the entire membrane layer, making the coating more uniform. It also results in a thinner membrane layer, resulting in higher sensitivity and smaller standard deviation.

[0176] In Examples 4 and 5, polyvinylpyridine is used for diffusion restriction, and in Examples 6 and 7, poly (4-vinylpyridine-co-polystyrene sulfonate) is used as the diffusion membrane. Since poly (4-vinylpyridine-co-polystyrene sulfonate) is negatively charged, the sensors of Examples 6 and 7 have a thinner membrane thickness, but their sensitivity to the substrate β-hydroxybutyrate is low. This is because β-hydroxybutyrate is also negatively charged in the test solution, so the membrane material has a certain repulsive effect on β-hydroxybutyrate (stronger diffusion restriction effect). The glucose substrate is a neutral molecule and is uncharged, so the glucose response of Examples 6 and 7 is higher than that of Examples 4 and 5.

[0177] Comparative Example 1

[0178] First, a monitoring probe with front and back dual working electrodes is prepared, namely a first working electrode and a second working electrode.

[0179] Next, a β-hydroxybutyrate sensitive layer solution and a glucose sensitive layer solution were prepared with the same formula as in Example 1. The glucose sensitive layer solution was deposited on the first working electrode, and the β-hydroxybutyrate sensitive layer solution was deposited on the second working electrode, forming a linear pattern. The glucose sensing layer had an area of ​​approximately 0.3 mm. 2 The ketone body sensing layer area is about 0.45mm 2 , that is, the area ratio of the glucose enzyme layer to the ketone body enzyme layer is 1:1.5; solidification is performed to obtain an electrode containing a dual-component response sensing layer of glucose and ketone bodies.

[0180] Then, the two-component response electrode obtained above was coated according to the same three-layer film formulation as in Example 1, and finally a two-component sensor with a film thickness of about 57 microns was obtained.

[0181] FIG. 14 is a picture showing a monitoring probe of Comparative Example 1 of the blood glucose + blood ketone sensor according to the present disclosure.

[0182] The sensor of Comparative Example 1 was immersed in a standard PBS buffer (pH 7.4) at 37° C.; a working voltage was applied relative to the reference electrode until a constant background current was reached, and the response current was measured under the corresponding concentrations of glucose / sodium β-hydroxybutyrate. The concentrations were as follows: 2.2 mM / 1 mM, 5 mM / 2 mM, 10 mM / 3 mM, 15 mM / 4 mM, 20 mM / 6 mM, and 25 mM / 8 mM, where the former represents the glucose concentration and the latter represents the sodium β-hydroxybutyrate concentration;

[0183] FIG. 15 is a graph showing a response current-test concentration curve of Comparative Example 1 of the blood glucose+blood ketone sensor according to the present disclosure.

[0184] The current response of the dual-component sensor of Comparative Example 1 to the concentration of sodium β-hydroxybutyrate showed good linearity, but the current response to the concentration of glucose was poor. Specifically, as shown in FIG15 , the linear curve R of the response current of the sensor to glucose and sodium β-hydroxybutyrate is shown in FIG15 . 2 They are 0.877 and 0.995 respectively, which shows that the glucose sensor is not linear in the range of 0-25mM. This may be because when responding to high concentrations, the amount of ketone body reaction is large, and the product will affect the response of the working electrode on the glucose side, resulting in the non-linear problem of high glucose concentration.

[0185] Comparative Example 2

[0186] First, a monitoring probe with front and back dual working electrodes is prepared, namely a first working electrode and a second working electrode.

[0187] Next, the β-hydroxybutyrate sensitive layer solution and the glucose sensitive layer solution were prepared with the same formula as in Example 1. The glucose sensitive layer solution was deposited on the first working electrode, and the β-hydroxybutyrate sensitive layer solution was deposited on the second working electrode, forming a linear pattern. The glucose sensing layer had an area of ​​approximately 0.3 mm. 2 The ketone body sensing layer area is about 0.27mm 2 ; solidification is performed to obtain an electrode containing a dual-component responsive sensing layer of glucose and ketone bodies.

[0188] Next, an 80% ethanol aqueous solution was prepared as the solvent, and polyvinylpyridine-b-polystyrene and PEGDGE were prepared into alcohol solutions of corresponding concentrations according to Table 5 to obtain a membrane solution. This membrane solution was then applied to the electrode deposited with the sensitive layer reagent to produce a dual-component monitoring working electrode containing an approximately 60-micron membrane layer.

[0189] Table 5. Diffusion-limiting membrane solution composition

[0190] FIG. 16 is a photograph showing a monitoring probe of Comparative Example 2 of the blood glucose + blood ketone sensor according to the present disclosure.

[0191] The sensor from Comparative Example 2 was immersed in standard PBS buffer (pH 7.4) at 37°C. A working voltage was applied until a constant background current was reached. The response current was then measured in the presence of glucose and sodium β-hydroxybutyrate at corresponding concentrations. The concentrations were as follows: 2.2mM / 1mM, 5mM / 2mM, 10mM / 3mM, 15mM / 4mM, 20mM / 6mM, and 25mM / 8mM, with the former indicating glucose concentration and the latter indicating sodium β-hydroxybutyrate concentration.

[0192] FIG17 is a graph showing the response current-test time curve of Comparative Example 2 of the blood glucose + blood ketone sensor of the present disclosure. As shown in FIG17 , the response of the dual-component sensor of Comparative Example 2 to glucose and sodium β-hydroxybutyrate shows good linearity. Specifically, the linear response current curve R of the sensor to glucose and sodium β-hydroxybutyrate is 2 Both were greater than 0.99, indicating a good linear relationship. The sensitivity of the glucose working electrode was 0.30 nA / mM, and that of the ketone body working electrode was 0.73 nA / mM. However, compared with Example 2, the sensitivity of both electrodes in Comparative Example 2 was lower, indicating that the addition of the compatibility and biocompatible membrane layers significantly improved the sensitivity of the electrodes.

[0193] Comparative Example 3

[0194] First, a monitoring probe with front and back dual working electrodes is prepared, namely a first working electrode and a second working electrode.

[0195] Next, the β-hydroxybutyrate sensitive layer solution and the glucose sensitive layer solution were prepared with the same formula as in Example 1. The glucose sensitive layer solution was deposited on the first working electrode, and the β-hydroxybutyrate sensitive layer solution was deposited on the second working electrode, forming a linear pattern. The glucose sensing layer had an area of ​​approximately 0.3 mm. 2 The ketone body sensing layer area is about 0.27mm 2 ; solidification is performed to obtain an electrode containing a dual-component responsive sensing layer of glucose and ketone bodies.

[0196] Next, ethanol was prepared as a solvent, and polyvinylpyridine and PEGDGE were mixed with alcohol solutions of corresponding concentrations according to Table 6 to obtain a diffusion-limiting membrane solution. This diffusion-limiting membrane solution was then applied to the electrode deposited with the sensitive layer reagent to produce a dual-component monitoring working electrode with a membrane layer of approximately 35 microns.

[0197] Table 6 Composition of diffusion limiting membrane solution

[0198] Finally, an 80% ethanol aqueous solution was prepared, and (poly-4-vinylpyridine-g-polyethylene glycol)-co-polystyrene and PEGDGE were prepared at corresponding concentrations according to Table 7 to obtain a biocompatible membrane solution; the biocompatible membrane solution was applied to the diffusion-limiting membrane of the working electrode to produce a working electrode containing a biocompatible membrane layer of approximately 25 microns and a total film thickness of approximately 60 microns.

[0199] Table 7 Biocompatible membrane solution composition

[0200] Figure 18 is a picture showing the monitoring probe of comparative example 3 of the blood glucose + blood ketone sensor according to the present disclosure. Figure 19 is a picture showing the monitoring probe of comparative example 3 of the blood glucose + blood ketone sensor according to the present disclosure from another perspective.

[0201] As shown in Figures 18 and 19, it can be seen that when the concentration of polymer (solute) in the diffusion-limiting membrane solution and the biocompatible membrane solution is high, if there is no compatible membrane layer, the morphology of the semipermeable membrane of the prepared sensor may shrink and the thickness may be uneven at the top and bottom, which is not conducive to the preparation of a highly consistent sensor.

[0202] [Blood glucose + lactate sensor]

[0203] Example 1

[0204] First, a monitoring probe with front and back dual working electrodes is prepared, namely a first working electrode and a second working electrode.

[0205] Secondly, prepare the lactic acid sensitive layer reagent raw materials (osmium coordinated metal polymer, lactate oxidase, stabilizer, cross-linking agent, etc.) according to the table below, dissolve each substance in the corresponding solvent buffer solvent according to the concentration parameters in the table, and ultrasonically vibrate to completely dissolve it to obtain the lactic acid sensitive layer solution of each embodiment.

[0206] Also according to the table below, prepare the glucose sensitive layer solution;

[0207] The large glucose sensitive layer solution was deposited on the first working electrode, and the lactic acid sensitive layer solution was deposited on the second working electrode, both forming a linear pattern, where the glucose sensing layer area was approximately 0.3 mm 2 , the area of ​​the lactic acid sensing layer is about 0.30mm 2 After solidification, an electrode containing a dual-component responsive sensing layer of glucose and lactic acid is obtained.

[0208] Then, ethanol was prepared as a solvent, and polyvinylpyridine and PEGDGE were mixed with alcohol solutions of corresponding concentrations according to the table below to obtain a diffusion-limiting membrane solution. A sensor containing a diffusion-limiting layer of approximately 30 microns was fabricated by the dip-coating method.

[0209] Similarly, prepare 80% ethanol aqueous solution, and mix poly (4-vinylpyridine-co-polystyrene) and PEGDGE with corresponding concentration solutions according to the table below to obtain a compatible membrane solution; and use the immersion and pulling method to make a sensor containing a compatible membrane layer of about 20 microns.

[0210] Similarly, an 80% ethanol aqueous solution was prepared, and (poly-4-vinylpyridine-g-polyethylene glycol)-co-polystyrene and PEGDGE were mixed at the corresponding concentrations shown in the table below to produce a biocompatible membrane solution. A sensor with a biocompatible membrane layer of approximately 20 microns and a total thickness of approximately 70 microns was fabricated using the dip-coating method. Figure 20 shows a photograph of the monitoring probe of Example 1 of the blood glucose + lactate sensor of the present disclosure.

[0211] The sensor was immersed in standard PBS buffer (pH 7.4) at 37 degrees; an operating voltage was applied until a constant background current was reached, and the response currents were measured at corresponding concentrations of glucose / lactic acid. The values ​​for each concentration were as follows: 2.2mM / 0.5mM, 5mM / 5mM, 10mM / 10mM, 15mM / 15mM, 20mM / 20mM, and 25mM / 25mM, where the former represents the glucose concentration and the latter represents the lactic acid concentration; FIG21 is a response current-test time graph showing Example 1 of the blood glucose + lactate sensor involved in the present disclosure.

[0212] As can be seen from Figure 21, the blood glucose + lactate dual-component sensor shows good linearity in response to glucose and lactate. The linear curves of the sensor's response current to glucose and lactate are R 2 Both are greater than 0.997, indicating a good linear relationship. The sensitivity of the glucose working electrode is 1.22nA / mM, and the sensitivity of the lactate working electrode is 1.51nA / mM.

[0213] [Blood Ketone Sensor]

[0214] Example 1, Comparative Examples 1-2

[0215] First, prepare a monitoring probe with a working electrode.

[0216] Next, according to Table 8, the sensitive layer reagent raw materials of each blood ketone sensor embodiment and comparative example were prepared (ruthenium coordinated metal polymer, β-hydroxybutyrate dehydrogenase, diaphorase, NAD + , stabilizer, cross-linking agent, etc., dissolve each substance in the corresponding solvent buffer solvent according to the concentration parameters in the table, and ultrasonically vibrate to completely dissolve it to obtain the β-hydroxybutyric acid sensitive layer solution of each embodiment.

[0217] The β-hydroxybutyric acid sensitive layer solution is deposited on the working electrode to form a linear pattern with a width of about 160 microns and a length of about 2.1 mm; and the solution is solidified to obtain an enzyme sensing layer.

[0218] Table 8. Examples of Blood Ketone Sensors

[0219] FIG. 22 is a picture showing the monitoring probes of the blood ketone sensor of Example 1 and Comparative Examples 1-2 according to the present disclosure.

[0220] Then, pure ethanol was prepared as a solvent, and polyvinylpyridine, polydimethylsiloxane, and PEGDGE were mixed with alcohol solutions of corresponding concentrations according to Table 9 to obtain a diffusion-limiting membrane solution. The diffusion-limiting membrane solution was then coated onto the working electrode on which the β-hydroxybutyrate-sensitive layer solution had been deposited, to produce a working electrode containing an approximately 20-micron diffusion-limiting membrane layer.

[0221] Table 9. Diffusion-limiting membrane solution composition

[0222] Prepare an 80% ethanol aqueous solution and prepare poly (4-vinylpyridine-co-polystyrene) and PEGDGE to corresponding concentrations according to Table 10 to obtain a compatible membrane solution. Coat the working electrode coated with the diffusion-limiting layer membrane with the compatible membrane solution to produce a working electrode containing an approximately 15 μm compatible membrane layer.

[0223] Table 10. Compatibility membrane solution composition

[0224] Prepare an 80% ethanol aqueous solution, and prepare (poly (4-vinylpyridine-g-polyethylene glycol))-co-polystyrene and PEGDGE to corresponding concentrations according to Table 11 to obtain a biocompatible membrane solution; coat the working electrode coated with the compatible membrane layer with the biocompatible membrane solution to produce a working electrode containing a biocompatible membrane layer of approximately 15 microns and a total film thickness of 50 microns.

[0225] Table 11. Biocompatible membrane solution composition

[0226] FIG. 23 is a picture showing monitoring probes coated with a polymer film layer according to Example 1 and Comparative Examples 1-2 of the blood ketone sensor of the present disclosure.

[0227] Finally, the linearity and stability tests of the ketone body biosensors obtained in Example 1 and Comparative Examples 1-2 were conducted:

[0228] (1) Linearity test:

[0229] The ketone body biosensor was immersed in standard PBS buffer (pH 7.4) at 37°C; an operating voltage was applied until the ketone body biosensor reached a constant background current, and sodium β-hydroxybutyrate at concentrations of 0mM, 1mM, 2mM, 3mM, 4mM, 6mM, and 8mM was added to the solution to measure the linearity of the reaction. After each addition of sodium β-hydroxybutyrate, the solution was allowed to equilibrate for 10 minutes, and the solution was continuously stirred during the measurement process to ensure a uniform concentration.

[0230] FIG24 is a graph showing the response current versus test concentration in a linearity test of Example 1 of the blood ketone sensor according to the present disclosure. FIG25 is a graph showing the response current versus test concentration in a linearity test of Example 1 of the blood ketone sensor according to the present disclosure. As shown in FIG24 and FIG25 , the ketone body biosensor of Example 1 of the blood ketone sensor exhibits good linearity in response to glucose. Specifically, the glucose sensor in Example 1 exhibits a good linear correlation between sodium β-hydroxybutyrate concentration and response current within the range of 0 mM to 8 mM.

[0231] (2) Stability test:

[0232] The ketone body biosensor was immersed in 3 mM sodium β-hydroxybutyrate (PBS buffer, pH 7.4) at 37°C and measured continuously for 14 days. FIG. 26 is a graph showing the response current versus test concentration curve of a stability test of Example 1 of the blood ketone sensor of the present disclosure. FIG. 27 is a graph showing the response current versus test concentration curve of a stability test of Comparative Example 1 of the blood ketone sensor of the present disclosure. FIG. 28 is a graph showing the response current versus test concentration curve of a stability test of Comparative Example 2 of the blood ketone sensor of the present disclosure.

[0233] As shown in Figures 26-28, Comparative Example 1 failed to maintain stability for 14 days at 37°C, and performance began to decline on the fifth day. However, both Example 1 and Comparative Example 2 maintained stability for 14 days because a stabilizer was added to the enzyme sensing layer, achieving longer-term stability for the ketone body sensor. The higher response value of Example 1 than Comparative Example 2 indicates that using HEPES buffer as the solvent for the sensitive layer reagent is superior to using PBS buffer as the solvent for the sensitive layer reagent.

[0234] Comparative Example 3

[0235] A monitoring probe having a working electrode was prepared in the same manner as in Example 1 for blood ketones, and an enzyme sensing layer was provided on the working electrode to obtain a sensor without a semipermeable membrane.

[0236] The sensor of Comparative Example 3 was exposed to a solution containing 1 mM sodium β-hydroxybutyrate in a standard PBS buffer (pH 7.4) at 37° C. under energy for 1 hour.

[0237] Figure 29 shows a graph of the response current versus test concentration for a linearity test of Comparative Example 3 of the blood ketone sensor of the present disclosure. As shown in Figure 29 , over the one-hour test period, the current signal generated by the sensor gradually decreased from 240 nA to below 155 nA, indicating poor stability. These test results demonstrate that sensors without a semipermeable membrane exhibit poor stability when testing the concentration of sodium β-hydroxybutyrate solutions.

[0238] Comparative Example 4

[0239] A monitoring probe having a working electrode was prepared in the same manner as in the blood ketone comparative example 4, and an enzyme sensing layer was provided on the working electrode to obtain a sensor without a semipermeable membrane.

[0240] Prepare an 80% ethanol aqueous solution, and mix poly (4-vinylpyridine)-co-polystyrene) and PEGDGE in corresponding concentrations according to the table below to obtain an inner membrane solution; apply the inner membrane solution to the working electrode provided with the enzyme sensing layer to produce a working electrode containing an approximately 35-micron poly (4-vinylpyridine)-b-polystyrene membrane layer.

[0241] Table 12 Inner membrane solution composition

[0242] Prepare an 80% ethanol aqueous solution, and configure (poly-4-vinylpyridine-g-polyethylene glycol)-co-polystyrene and PEGDGE to corresponding concentration solutions according to Table 13 to obtain an outer membrane solution; coat the working electrode coated with the inner membrane with the outer membrane solution to prepare a working electrode containing an outer membrane of about 15 microns and a total membrane thickness of 50 microns.

[0243] Table 13 Outer membrane solution composition

[0244] FIG30 is a photograph showing a monitoring probe of a sensor of Comparative Example 4 of the blood ketone sensor according to the present disclosure.

[0245] Finally, the obtained ketone body sensor was subjected to a stability test; that is, the comparative example 4 ketone body biosensor was immersed in 3 mM sodium β-hydroxybutyrate (PBS buffer pH 7.4 as solvent) at 37° C.; and the measurement was continued for 3 days.

[0246] FIG31 is a graph showing the response current versus test time of the sensor of Comparative Example 4 of the present disclosure. As shown in FIG31 , the initial response current of the sensor of Comparative Example 4 was 15.6 nA. After three days, the response current of the sensor decreased to 11.2 nA, a total decrease of 28.2%, with an average daily decrease of 9.4%. This indicates that the sensor coated only with the poly (4-vinylpyridine)-b-polystyrene and (poly (4-vinylpyridine)-g-polyethylene glycol)-co-polystyrene membranes has poor stability.

[0247] The main reason is that the membrane layer combination has a higher permeability to sodium β-hydroxybutyrate than that of blood ketone Example 1, indicating that the diffusion restriction effect of the membrane is not strong enough to reduce the permeability of sodium β-hydroxybutyrate, and the small molecule escape effect of the enzyme layer is restricted, resulting in its poor stability.

[0248] Comparative Example 5

[0249] First, prepare a monitoring probe with a working electrode.

[0250] The corresponding reagents were prepared according to the same enzyme layer formula as in Blood Ketone Example 1. Using an ultra-micropipette robot, the β-hydroxybutyrate sensitive layer solution was drop-coated onto the working electrode to form a pattern of six independent dots with a diameter of 150 microns. Curing was then performed to obtain an enzyme sensor having a six-dot pattern. Figure 32 is a photograph of the working electrode of the sensor of Comparative Example 5 of the Blood Ketone Sensor of the present disclosure.

[0251] Then, the 6-dot pattern enzyme sensor was coated with a film according to the same film coating scheme as in Example 1 for blood ketone analysis, yielding the ketone body sensor of Comparative Example 5. Finally, the resulting ketone body sensor of Comparative Example 5 was subjected to a linearity test: the ketone body biosensor was immersed in standard PBS buffer (pH 7.4) at 37°C; an operating voltage was applied until the ketone body biosensor reached a constant background current, and sodium β-hydroxybutyrate at concentrations of 1 mM, 2 mM, 3 mM, 4 mM, 5 mM, 6 mM, 7 mM, and 8 mM was added to the solution to measure the linearity of the reaction. After each addition of sodium β-hydroxybutyrate, the solution was continuously stirred during the measurement to ensure a uniform concentration.

[0252] FIG33 is a graph showing the response current versus test concentration for a linearity test of the blood ketone sensor Comparative Example 5 of the present disclosure. As shown in FIG33 , the sensor exhibits good linearity in response to sodium β-hydroxybutyrate within the 0-8 mM concentration range, but exhibits low sensitivity. Specifically, the slope of the linear fitting curve is 0.677 nA / mM. While the sensitivity of the sensor in Example 1 is 2.08 nA / mM, that of Comparative Example 5 is only 32.5% of that of Example 1. This is due to the smaller enzyme layer area in Comparative Example 5, resulting in a lower reaction area with sodium β-hydroxybutyrate permeating the membrane layer. This demonstrates that increasing the enzyme layer area can effectively increase sensor sensitivity.

[0253] In summary, according to the present disclosure, a multi-analyte sensor can be provided that can continuously monitor multiple analytes simultaneously, has a simple manufacturing process, and has high sensitivity and stability.

[0254] Various examples of the present disclosure have been described above in the detailed description. Although these descriptions directly describe the above examples, it should be understood that modifications and / or variations of the specific examples shown and described herein may be conceivable to those skilled in the art. Any such modifications or variations that fall within the scope of this specification are also intended to be included therein. Unless otherwise specified, it is the inventor's intention that the terms in the specification and claims be given their ordinary and customary meanings as given to those of ordinary skill in the art.

Claims

1. A multi-analyte monitoring sensor, characterized in that: The sensor comprises a working electrode, an enzyme sensing layer disposed on the working electrode, and a polymer membrane layer. The working electrode comprises a first working electrode and a second working electrode; The enzyme sensing layer comprises a first analyte enzyme layer and a second analyte enzyme layer, the first analyte enzyme layer is disposed on the first working electrode, the second analyte enzyme layer is disposed on the second working electrode, and the second analyte is different from the first analyte; The polymer membrane layer is permeable to the first analyte and the second analyte and covers the first analyte enzyme layer and the second analyte enzyme layer.

2. The multi-analyte monitoring sensor according to claim 1, characterized in that: The first analyte is glucose.

3. The multi-analyte monitoring sensor according to claim 1 or 2, characterized in that: The second analyte is any one of β-hydroxybutyrate, lactate, ethanol, uric acid, urea, acetylcholine, amylase, bilirubin, cholesterol, chorionic gonadotropin, creatine kinase, creatine, creatinine, DNA, fructosamine, glutamine, hormones, ketone bodies, lactate, oxygen, peroxide, prostate-specific antigen, prothrombin, RNA, troponin, digitoxin, digoxin, theophylline, warfarin or antibiotics.

4. The multi-analyte monitoring sensor according to claim 1 or 2, characterized in that: The polymer film layer includes a film polymer, and the film polymer is a vinyl pyridine polymer, polyurethane, sodium polystyrene sulfonate, poly(N-isopropylacrylamide), polyacrylic acid, polyvinyl alcohol, polyvinyl pyrrolidone, poly(oligo(ethylene glycol) methyl ether methyl methacrylate), or a block copolymer or blend of the above polymers.

5. The multi-analyte monitoring sensor according to claim 4, characterized in that: The polymer film layer further comprises a cross-linking agent and a regulator, and the mass fraction of the membrane polymer in the polymer film layer is 80% to 100%.

6. The multi-analyte monitoring sensor according to claim 1 or 2, characterized in that: The polymer film layer is biocompatible.

7. The multi-analyte monitoring sensor according to claim 6, characterized in that: The polymer membrane layer includes a first membrane layer that is biocompatible and has a diffusion-limiting effect on the first analyte and the second analyte.

8. The multi-analyte monitoring sensor according to claim 6, characterized in that: The polymer membrane layer includes a first membrane layer having a diffusion limiting effect on the first analyte and the second analyte, and a second membrane layer having biocompatibility, wherein the second membrane layer is farther away from the enzyme sensing layer than the first membrane layer.

9. The multi-analyte monitoring sensor according to claim 1, characterized in that: The sensitivity of the first working electrode differs from the sensitivity of the second working electrode by no more than 6 times.

10. The multi-analyte monitoring sensor according to claim 1 or 9, characterized in that: The area of ​​the first analyte enzyme layer is larger or smaller than the area of ​​the second analyte enzyme layer.

11. The multi-analyte monitoring sensor according to claim 1 or 9, characterized in that: The polymer membrane layer includes a negatively charged membrane layer having a diffusion limiting effect on the first analyte and the second analyte.

12. The multi-analyte monitoring sensor according to claim 3, characterized in that: The second analyte is β-hydroxybutyrate, and the second analyte enzyme layer includes hydroxybutyrate dehydrogenase, diaphorase, coenzyme, and electron mediator. In the second analyte enzyme layer, the mass fraction of hydroxybutyrate dehydrogenase is 10% to 35%, the mass fraction of diaphorase is 5% to 40%, the mass fraction of coenzyme is 10% to 45%, and the mass fraction of the electron mediator is 10% to 50%.

13. The multi-analyte monitoring sensor according to claim 1, characterized in that: The sensor further comprises a substrate, and the working electrode is disposed on the substrate.

14. The multi-analyte monitoring sensor according to claim 13, characterized in that: The sensor further includes a reference electrode and a counter electrode. The first working electrode and the second working electrode are respectively located on two sides of the substrate. The reference electrode and the counter electrode are respectively located on two sides of the substrate.

Citation Information

Patent Citations

  • Biosensor and preparation method thereof and polymer film layer for biosensor

    CN112014448A

  • Analyte sensors and sensing methods featuring dual detection of glucose and ketones

    CN113329689A

  • Analyte sensors and sensing methods for dual detection of glucose and ethanol

    CN113453620A

  • Multi-analyte monitoring sensor

    CN116735885A

  • Microbiosensor having thin-layer passage and dialysis membrane

    JP2006126092A